| Dr Michael Thornton Newcomb, MD | |
|
100 N Eagle Creek Dr, Lexington, KY 40509-1805 | |
| (859) 258-5310 | |
| (859) 258-6123 |
| Full Name | Dr Michael Thornton Newcomb |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 100 N Eagle Creek Dr, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093968026 | NPI | - | NPPES |
| 0169 | Other | KY | LC MEDICARE GROUP ID NUMBER |
| 65923740 | Other | KY | LC MEDICAID GROUP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 45025 (Kentucky) | Primary |
| 207W00000X | Ophthalmology | R1832 (Kentucky) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Lexington Clinic, Psc | 3476457532 | 310 |
News Archive
The American Society for Radiation Oncology Clinical Affairs and Quality Committee has developed a guideline for the use of radiation therapy in treating bone metastases. The guideline will be published in the International Journal of Radiation Oncology-Biology-Physics, an official journal of ASTRO.
The intersection of graphene with stem cell biology may one day lead to new treatments for osteoarthritis, say researchers at Boise State University. Impacting millions of people across the globe, osteoarthritis is the most prevalent form of arthritis.
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer.
BDNews24.com reports on a new $13 million U.S.-government initiative aimed at "providing HIV-prevention services to two million at-risk people in Bangladesh including injecting drug users, male, female and transgender sex workers and their clients, and HIV-positive people through a network of 50 health centres." USAID will partner with Family Health International (FHI) to implement the program (9/17).
KYTHERA Biopharmaceuticals, Inc. today announced the completion of enrollment in two pivotal U.S. and Canadian Phase III clinical trials of ATX-101, a potential first-in-class injectable facial aesthetic drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA expects to release top-line results in mid-2013.
› Verified 7 days ago
| Entity Name | New Lexington Clinic Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803681 PECOS PAC ID: 3476457532 Enrollment ID: O20031121000103 |
News Archive
The American Society for Radiation Oncology Clinical Affairs and Quality Committee has developed a guideline for the use of radiation therapy in treating bone metastases. The guideline will be published in the International Journal of Radiation Oncology-Biology-Physics, an official journal of ASTRO.
The intersection of graphene with stem cell biology may one day lead to new treatments for osteoarthritis, say researchers at Boise State University. Impacting millions of people across the globe, osteoarthritis is the most prevalent form of arthritis.
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer.
BDNews24.com reports on a new $13 million U.S.-government initiative aimed at "providing HIV-prevention services to two million at-risk people in Bangladesh including injecting drug users, male, female and transgender sex workers and their clients, and HIV-positive people through a network of 50 health centres." USAID will partner with Family Health International (FHI) to implement the program (9/17).
KYTHERA Biopharmaceuticals, Inc. today announced the completion of enrollment in two pivotal U.S. and Canadian Phase III clinical trials of ATX-101, a potential first-in-class injectable facial aesthetic drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA expects to release top-line results in mid-2013.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Thornton Newcomb, MD 350 Elaine Dr, Suite 204, Lexington, KY 40504-2754 Ph: (859) 258-4339 | Dr Michael Thornton Newcomb, MD 100 N Eagle Creek Dr, Lexington, KY 40509-1805 Ph: (859) 258-5310 |
News Archive
The American Society for Radiation Oncology Clinical Affairs and Quality Committee has developed a guideline for the use of radiation therapy in treating bone metastases. The guideline will be published in the International Journal of Radiation Oncology-Biology-Physics, an official journal of ASTRO.
The intersection of graphene with stem cell biology may one day lead to new treatments for osteoarthritis, say researchers at Boise State University. Impacting millions of people across the globe, osteoarthritis is the most prevalent form of arthritis.
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer.
BDNews24.com reports on a new $13 million U.S.-government initiative aimed at "providing HIV-prevention services to two million at-risk people in Bangladesh including injecting drug users, male, female and transgender sex workers and their clients, and HIV-positive people through a network of 50 health centres." USAID will partner with Family Health International (FHI) to implement the program (9/17).
KYTHERA Biopharmaceuticals, Inc. today announced the completion of enrollment in two pivotal U.S. and Canadian Phase III clinical trials of ATX-101, a potential first-in-class injectable facial aesthetic drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA expects to release top-line results in mid-2013.
› Verified 7 days ago
David R. Kielar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-258-5310 Fax: 859-258-5328 | |
Dr. Jon David Hammer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 120 N Eagle Creek Dr Ste 211, Lexington, KY 40509 Phone: 859-263-3030 Fax: 859-263-2491 | |
Dr. Peter John Timoney, MBBCH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Conn Ter Ste 550, Lexington, KY 40508 Phone: 859-323-5867 Fax: 859-323-1122 | |
Mohamed Magdy Khodeiry, MD, MSC Ophthalmology Medicare: Medicare Enrolled Practice Location: 110 Conn Ter Ste 550, Lexington, KY 40508 Phone: 859-323-5867 Fax: 859-323-8510 | |
John C. Sparrow, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 100 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-258-5310 Fax: 859-258-5328 | |
Dr. Jitander Singh Dudee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2351 Huguenard Drive, Suite 100, Lexington, KY 40503 Phone: 859-278-9486 Fax: 888-500-3329 | |
Alexander James Cherry, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 849-323-5867 |